GlassScriptPhysician profile
Travis P Martin
NPI 1053874305
$9,950.75
in general payments reported to CMS, 2019-2025
25 companies · $4,318 in 2025
The $4,318 reported for 2025 was more than what 90% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $963 · 2023: $1,157 · 2024: $3,512 · 2025: $4,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,596 · Travel and Lodging: $3,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,596.34 |
| Travel and Lodging | $3,391.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,332.35 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Accurian |
| Boston Scientific Corporation | $2,279.79 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Spr Therapeutics, INC | $578.80 | 2022-2024 | Sprint Pns System |
| Foundation Fusion Solutions, LLC | $364.04 | 2024-2025 | |
| Nalu Medical, INC. | $328.32 | 2024-2025 | Nalu Neurostimulation System |
| Curonix LLC | $276.40 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $253.10 | 2024-2025 | Proclaim, Eterna |
| Nevro Corp. | $246.17 | 2024 | Senza |
| Abbvie INC. | $217.26 | 2023-2025 | |
| Globus Medical, INC. | $152.26 | 2025 | Vyrsa V1, Senza |
| Saluda Medical Americas, INC. | $148.71 | 2025 | Evoke |
| Mml US, INC. | $144.69 | 2022 | |
| Vertos Medical, INC. | $142.28 | 2023 | Mild Device Kit |
| Averitas Pharma INC. | $134.29 | 2023-2024 | Qutenza |
| Si-Bone, INC. | $47.81 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $45.90 | 2024-2025 | Genvisc 850 Sodium Hyaluronate |
| Collegium Pharmaceutical, INC. | $45.10 | 2025 | Belbuca |
| Pacira Pharmaceuticals Incorporated | $44.87 | 2025 | Exparel |
| Relievant Medsystems, INC. | $35.42 | 2023 | Intracept |
| Painteq LLC | $35.06 | 2023 | Painteq |
| Cornerstone Medical Associates, INC. | $22.70 | 2024 | |
| Ethicon US, LLC | $20.78 | 2024 | Echelon; Endopath |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.49 | 2025 | Relistor |
| Vertex Pharmaceuticals Incorporated | $18.44 | 2025 | |
| Spinal Simplicity, LLC | $15.72 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.